Outset Medical (OM) Research & Development (2019 - 2026)

Outset Medical (OM) has reported Research & Development for 8 consecutive years, with $12.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development fell 14.9% year-over-year to $12.2 million in Q2 2026; TTM through Jun 2026 was $51.9 million, a 11.8% decrease from a year earlier, with the FY2025 full-year figure at $54.4 million, down 22.39% from the prior year.
• Research & Development was $12.2 million for Q2 2026 at Outset Medical, down from $13.3 million in the prior quarter.
• Over five years, Research & Development peaked at $25.0 million in Q2 2023 and troughed at $12.2 million in Q2 2026.
• A 5-year average of $18.6 million and a median of $19.3 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development jumped 75.69% in 2022 and tumbled 37.63% in 2024, its largest moves.
• Over 5 years, Research & Development stood at $23.6 million in 2022, then decreased by 6.08% to $22.2 million in 2023, then plunged by 30.38% to $15.5 million in 2024, then retreated by 16.65% to $12.9 million in 2025, then dropped by 5.64% to $12.2 million in 2026.
• The last three Research & Development figures came in at $12.2 million (Q2 2026), $13.3 million (Q1 2026), and $12.9 million (Q4 2025), per Business Quant data.